AMSBIO
AMSBIO is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries.
Latest AMSBIO Content
Product News
Validated Tumor Tissue Samples for Cancer Research
CancerSeq™ FFPE tissues from AMSBIO are pre-screened tumor tissue samples for single nucleotide polymorphisms (SNP’s), insertions and deletions plus copy number variations (CNVs) using targeted Next Generation Sequencing to identify key mutations.
Product News
Laminin Isoform Kit Streamlines Cell Culture Workflow
For researchers looking to optimize protocols for cell culture and differentiation of ES/iPS cells - AMSBIO has introduced the iMatrix Palette.
Product News
Direct Translocation of Proteins Into Living Cells
BioPORTER® protein delivery reagent from AMSBIO is proven to efficiently transport functionally active proteins directly into living cells eliminating the traditional DNA transfection, transcription, and protein translation process.
Product News
Immunofluorescent Staining Within Hours, Not Days
AMSBIO has launched CellO-IF – an all-in-one immunofluorescent staining reagent kit designed to accelerate the labelling organoids and spheroids directly in hydrogels or extracellular matrices.
Product News
Tailor Made Transduction-Ready Viral Particles
AMSBIO offers a production service for high quality custom transduction-ready viral particles designed to support your research and save you valuable time.
Product News
Sensitive Detection of Cell Culture Mycoplasma Infection
The MycoScope™ Mycoplasma PCR detection kit from AMSBIO uses polymerase chain reaction (PCR) technology to detect mycoplasma infections in less than 3 hours.
Product News
Culture Techniques for Drug Discovery and Therapeutics
AMSBIO has published an informative online article that reviews the importance of culture techniques for induced pluripotent stem cells (iPSCs), which provide an invaluable resource for drug discovery and therapeutic applications.
Product News
Genetically Engineered iPSCs Offer Improved Efficiency and Cost Savings
AMSBIO has launched a range of genetically engineered Induced Pluripotent Stem Cells (iPSCs) developed to provide improved model fidelity over cell lines and biochemical assays used for drug discovery and cell therapy research.
Product News
GLP-1R Reporter Cell Line for Diabetes / Obesity Research
AMSBIO has launched a Glucagon-Like Peptide 1 Receptor (GLP-1R) reporter cell line.
Product News
Products for Sustainable Food Development
AMSBIO offers a range of kits, media and reagents enabling development of food in a way that is not wasteful of our natural resources and is not detrimental to the environment or consumer health.
Advertisement
